SMCI Just Dropped 28% in Two Days. Here’s What the Options Market Is Telling You Right Now.
A $7 billion equity raise, $39 billion in AI server orders, and a stock in freefall — the setup is messier than it looks.
Category: Top News
Marvell Just Got Called the Next Trillion-Dollar Company. Here’s What the Numbers Actually Say.
MRVL posted record revenue and a wave of analyst upgrades. The question is whether the tape has already priced the future.
Goldman Sachs Just Repriced. The Question Is Whether It Deserves To Stay There.
Record equities, a four-year-high M&A backlog, and a SpaceX IPO mandate — GS is firing on almost every cylinder. Almost.
The Healthcare Sector Has Been Left for Dead. That’s the Setup Bargain Hunters Have Been Waiting For.
Three years of underperformance, a 20% valuation discount, and a mean-reversion case that’s getting harder to ignore.
Broadcom Just Priced In Perfection. Then Delivered Something Slightly Less.
AVGO drops 12%+ on a quarter that beat EPS — here’s the real story behind the selloff
MercadoLibre Is Down 33% From Its Peak. That Might Be the Whole Story.
MELI posted 49% revenue growth in Q1 2026. The stock barely moved. Something doesn’t add up.
Advanced Micro Devices Is Being Mispriced by the Market – and the Data Tells a Different Story
AMD’s -1.00% pullback on June 1 looks like noise. The underlying structural thesis is far more durable than today’s headline suggests.
Jensen Huang Called It a $40 Trillion Market. Here’s the Cheap Way to Play Physical AI.
Humanoid robotics is moving from factory demos to investor portfolios – and the picks-and-shovels angle is cleaner than most people realize
META Is Down 6% This Year. The Business Grew 33%. Something Doesn’t Add Up.
The most misunderstood Magnificent Seven stock is quietly building one of the cheapest setups in mega-cap tech
Eli Lilly (LLY): The GLP-1 Trade Is Bigger Than the Market Thinks
Mounjaro up 125%. Zepbound up 79%. A new oral pill just launched. The growth story keeps widening.